Finance

Can AI Bridge the Gap Between Care and Billing?
Process Can AI Bridge the Gap Between Care and Billing?

The chasm separating the delivery of patient care from the administrative complexities of billing has become a primary source of financial instability for healthcare organizations nationwide. While clinicians dedicate themselves to healing, their efforts are frequently devalued by a documentation

Is This the End of Prescription Sticker Shock?
Care Is This the End of Prescription Sticker Shock?

The simple act of a doctor sending a prescription to a pharmacy often triggers a hidden wave of anxiety for patients, who are left to wonder if the path to health is one they can actually afford. This moment, filled with both hope for recovery and fear of cost, highlights a critical fracture in the

Key Strategies Boost Outpatient Program Retention
Care Key Strategies Boost Outpatient Program Retention

The expanding landscape of behavioral healthcare hinges on the successful implementation of intermediate care models, yet their very foundation is threatened by a persistent and costly retention crisis. Intensive Outpatient (IOP) and Partial Hospitalization (PHP) programs represent a critical

Healthcare and Life Sciences Expect an M&A Surge
Business Healthcare and Life Sciences Expect an M&A Surge

Today we're joined by Faisal Zain, a veteran expert in medical technology whose career has been dedicated to advancing the manufacturing and innovation of critical diagnostic and treatment devices. His deep understanding of the intersection between technology and healthcare finance provides a

Can New Funding Fix Clinical Trial Patient Recruitment?
Organizational Governance Can New Funding Fix Clinical Trial Patient Recruitment?

The journey of a life-saving drug from a laboratory concept to a patient’s hands is one of the most complex and expensive undertakings in modern science, yet it is often stalled not by scientific complexity, but by the profoundly human challenge of finding the right people to participate in c

Is Innovation Enough for Biopharma's Survival?
Care Is Innovation Enough for Biopharma's Survival?

The echo of groundbreaking scientific achievement in the biopharmaceutical sector is being increasingly muffled by the persistent drumbeat of an unsustainable business model, creating a dissonance that threatens the industry's long-term health. An exhaustive analysis of strategic forecasts and

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later